Total net revenue of $15.2 million Adjusted EBITDA1 of $ (0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) ...

Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at December 31, 2025Company launched EXXUA (gepirone) extended-r ...

Every CEO in the Fortune 500 has issued some version of the same mandate: We need an AI strategy. Most of them have also ...

Tim Greimel’s term as Pontiac’s mayor is over. He dropped his re-election bid a year ago, opting instead to run for the 10th ...

Illinois officials started a new “Ride Safe, Ride Smart, Ride Ready" program to create tougher rules for fast e-bikes, ...

The speakers will be Cheryl Anderson, professor and dean of the Herbert Wertheim School of Public Health and Longevity ...

Donald Trump’s destruction of the civil service is a tragedy not just for the roughly 300,000 workers who have been discarded ...

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

Send event details (who, what, where, when, cost and contact information) in an email to ehimchak@pomeradonews.com. The deadline is noon Friday. Items run on a space available ...

To ensure that no patient is left behind in receiving this potentially life-saving therapy, Mesoblast has established a patient access hub termed MyMesoblast™, where Ryoncil ® is available for ...

Satellos Bioscience Inc. ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced positive topline three-year functional results from Part 1-treated patients in EMBARK (Study ...